For the second consecutive year, he has been named among Becker’s Hospital Review’s Top 96 CEOs of Academic Medical Centers for 2024, a testament to his leadership in advancing one of the Middle East’s most prestigious healthcare institutions.
CEO
Majid Al-Fayyadh
H.E. Dr. Majid bin Ibrahim Al-Fayyadh, Chief Executive Officer of King Faisal Specialist Hospital & Research Centre (KFSH&RC), stands as one of the rare physician-leaders who have successfully bridged clinical medicine, executive management, and scientific research.

Career Journey and Clinical Expertise
Dr. Al-Fayyadh’s medical background is rooted in Pediatric Cardiology, holding a fellowship from Columbia University, New York, preceded by a Pediatric Fellowship from Tufts University, Boston. He also earned a Master’s in Medical Management from the University of Southern California in 2015. His research has been recognized with multiple grants, including the Harvard Medical Research Foundation Grant for a multi-center international study on the genetic causes of congenital heart defects. Before becoming CEO, he held several key positions at KFSH&RC, including: – Deputy CEO for Medical and Clinical Affairs – overseeing medical departments, pharmacy, patient services, and health IT applications – Deputy Director – King Faisal Specialist Hospital Heart Center – Executive Lead – Cardiology Information Systems Project He also served as an Advisor at the Vision Realization Office – Ministry of Health, and is currently a member of the Health Sector Transformation Program Committee under the National Transformation Program, part of Saudi Vision 2030.
Key Achievements at KFSH&RC
– Led the hospital’s transformation into an independent, non-profit institution – Strengthened clinical strategy, patient experience, operational productivity, research strategy, and education programs – Achieved global recognition, ranking 20th among the world’s best healthcare institutions and #1 in the Middle East & Africa (Brand Finance, 2023) – Invited to speak at Harvard University’s Gulf Innovators Conference 2024 – Named among Forbes Middle East’s Top Healthcare Leaders in 2023
Board and Governance Roles
– Board Member – King Saud University (first Board of Directors in the university’s history) – Trustee – Alfaisal University – Member – Saudi Health Council – Trustee – King Salman Center for Disability Research
Leadership Impact
Dr. Al-Fayyadh is a key driver of the Saudi Health Sector Transformation Program, aligning KFSH&RC’s growth with Vision 2030 goals. His leadership philosophy blends evidence-based medicine, strategic governance, and innovation, positioning KFSH&RC as a global benchmark for academic medical excellence.
Share on